相关实验视频
Updated: May 13, 2025

04:23
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
184
萨尔科佩尼亚/肝硬化中的脆弱性分子病原体
Huanli Jiao1, Han Wang1, Jia Li2
1Department of Health Management, Tianjin Hospital, Hexi District, Tianjin, People's Republic of China.
Seminars in liver disease
|April 16, 2025
概括
肝硬化患者通常会因为炎症和营养不良等复杂因素而患上缩症和虚弱. 早期诊断和管理对于慢性肝病的更好的结果至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 老年病的医生 老年病的医生
- 肌肉的新陈代谢
背景情况:
- 肝硬化是慢性肝病的严重阶段,导致显著的发病率和死亡率.
- 脱补偿性肝硬化会出现危及生命的并发症,如水出血,肝脑病和肝综合征.
- 肉症 (肌肉损失) 和脆弱性在肝硬化患者中很普遍,影响生活质量和增加医疗保健成本.
研究的目的:
- 为了阐明在肝硬化患者中 Sarcopenia 和 Frailty 的复杂病原性.
- 为了突出肝纤维化进展和萨尔科佩尼亚/脆弱性发展之间的复杂关系.
- 强调对这些重叠疾病的早期诊断和有效管理策略的需要.
主要方法:
- 本综述综合了当前关于肝硬化,肉症和脆弱性的科学文献.
- 它检查了多因素原因,包括全身炎症,肌肉蛋白代谢,营养不良和内分泌功能障碍.
- 该综述分析了肝纤维化和肉症/脆弱性进展之间的相互影响.
主要成果:
- 肉症和脆弱性在肝硬化中很常见,源于系统性炎症,代谢失衡,营养不良和身体活动减少.
- 这些条件可以在肝硬化发作之前出现,这表明与肝纤维化有显著联系.
- 病变发生是多因素的,涉及肌肉蛋白代谢,内分泌问题和肠道微生物组的改变.
结论:
- 肉症和脆弱性是肝硬化症的重要并发症,其起源复杂,多因素.
- 肝纤维化的进展与萨尔科佩尼亚和脆弱的发展和严重程度密切相关.
- 早期识别和干预对于管理患有肉病和虚弱的肝硬化患者至关重要,改善预后并减少疾病负担.
相关概念视频
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Overview of Protein Metabolism
584
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
584
Cross-bridge Cycle
115.9K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
115.9K
Bone Disorders
3.3K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.3K

